GZR 123

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2017-2017
012320172017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Background Given the high mortality rate for patients with end-stage kidney disease receiving dialysis and the efficacy and… (More)
Is this relevant?
2018
2018
AIM Recently, elbasvir/grazoprevir combination therapy (EBR/GZR) was reported to have excellent antiviral effects for chronic… (More)
Is this relevant?
2017
2017
Among patients with chronic kidney disease (CKD) in the United States, HCV infection causes significant morbidity and mortality… (More)
Is this relevant?
2017
2017
BACKGROUND The presence of baseline NS5A resistance-associated variants (RAVs) impacted treatment response in HCV genotype 1a… (More)
Is this relevant?
2017
2017
OBJECTIVE To evaluate the cost-utility of treatment with elbasvir/grazoprevir (EBR/GZR) regimens compared with ledipasvir… (More)
  • figure 1
  • table 1
  • table 2
  • table 2
  • table 3
Is this relevant?